Literature DB >> 20080072

Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program.

Eiji Konishi1, Yoko Kitai, Yukiko Tabei, Koichi Nishimura, Seiya Harada.   

Abstract

Japanese encephalitis (JE) is a serious disease in Asia, but it can be prevented by vaccination. To evaluate the necessity for vaccination in areas with reduced numbers of vector mosquitoes, as well as patients, it is critical to understand the frequency of natural virus exposure. An antibody survey was recently conducted to estimate current natural infection rates in Japan, where the vaccination rate has dropped in recent years. Serum samples were collected in 2004-2008 from inhabitants of Kumamoto Prefecture in west Japan, and in 2004-2006 from the Tokyo Metropolitan area of east Japan. Average annual infection rates estimated from the prevalence of antibodies to the nonstructural 1 protein (NS1) of JE virus was 1.8% in Kumamoto and 1.3% in Tokyo. When estimated from percentages of populations with detectable neutralizing antibodies but with no vaccination history, the average annual infection rate was 2.6% in both survey areas. Thus, JE virus remains present and active in nature in Japan. Therefore, continuing a vaccination program is indispensable to prevent JE infection in humans. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080072     DOI: 10.1016/j.vaccine.2010.01.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.

Authors:  Amy Sarah Ginsburg; Ankita Meghani; Scott B Halstead; Mansour Yaich
Journal:  Hum Vaccin Immunother       Date:  2017-08-25       Impact factor: 3.452

2.  Epidemiological Features of Japanese Encephalitis in Taiwan from 2000 to 2014.

Authors:  Yu-Kang Chang; Hsiao-Ling Chang; Ho-Sheng Wu; Kow-Tong Chen
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

Review 3.  Estimated global incidence of Japanese encephalitis: a systematic review.

Authors:  Grant L Campbell; Susan L Hills; Marc Fischer; Julie A Jacobson; Charles H Hoke; Joachim M Hombach; Anthony A Marfin; Tom Solomon; Theodore F Tsai; Vivien D Tsu; Amy S Ginsburg
Journal:  Bull World Health Organ       Date:  2011-08-03       Impact factor: 9.408

4.  Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.

Authors:  Ran Wang; Lyu Xie; Na Gao; Dongying Fan; Hui Chen; Peigang Wang; Hongning Zhou; Jing An
Journal:  Virol Sin       Date:  2019-03-25       Impact factor: 4.327

Review 5.  Epidemiology of Japanese encephalitis: past, present, and future prospects.

Authors:  Huanyu Wang; Guodong Liang
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

6.  The Spatio-temporal Distribution of Japanese Encephalitis Cases in Different Age Groups in Mainland China, 2004 - 2014.

Authors:  Xiaolong Li; Shiheng Cui; Xiaoyan Gao; Huanyu Wang; Miao Song; Minghua Li; Shihong Fu; Zhi Lv; Ying He; Wenwen Lei; Bin Wang; Xiaoqing Lu; Guodong Liang
Journal:  PLoS Negl Trop Dis       Date:  2016-04-06

7.  Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody.

Authors:  Rumi Sato; Nobuyuki Hamada; Takahito Kashiwagi; Yoshihiro Imamura; Koyu Hara; Munetsugu Nishimura; Tomoko Kamimura; Tomohiko Takasaki; Hiroshi Watanabe; Takeharu Koga
Journal:  Trop Med Health       Date:  2015-02-04

8.  TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection.

Authors:  Daisuke Hayasaka; Kenji Shirai; Kotaro Aoki; Noriyo Nagata; Dash Sima Simantini; Kazutaka Kitaura; Yuki Takamatsu; Ernest Gould; Ryuji Suzuki; Kouichi Morita
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  The incidence of Japanese encephalitis in Taiwan--a population-based study.

Authors:  Li-Ching Hsu; Yu-Ju Chen; Feng-Kuang Hsu; Jyh-Hsiung Huang; Chi-Ming Chang; Pesus Chou; I-Feng Lin; Feng-Yee Chang
Journal:  PLoS Negl Trop Dis       Date:  2014-07-24

10.  Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010.

Authors:  Eun Ju Lee; Go-Woon Cha; Young Ran Ju; Myung Guk Han; Won-Ja Lee; Young Eui Jeong
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.